Annual Total Debt
$9.40 M
-$1.74 M-15.59%
31 December 2023
Summary:
Vanda Pharmaceuticals annual total debt is currently $9.40 million, with the most recent change of -$1.74 million (-15.59%) on 31 December 2023. During the last 3 years, it has fallen by -$4.21 million (-30.92%). VNDA annual total debt is now -99.77% below its all-time high of $4.07 billion, reached on 01 December 2002.VNDA Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$7.94 M
-$491.00 K-5.82%
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly total debt is currently $7.94 million, with the most recent change of -$491.00 thousand (-5.82%) on 30 September 2024. Over the past year, it has dropped by -$1.91 million (-19.36%). VNDA quarterly total debt is now -49.01% below its all-time high of $15.57 million, reached on 31 March 2019.VNDA Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.6% | -19.4% |
| 3 y3 years | -30.9% | -37.7% |
| 5 y5 years | +100.0% | -46.8% |
VNDA Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -30.9% | at low | -37.7% | at low |
| 5 y | 5 years | -35.6% | -46.8% | at low | |
| alltime | all time | -99.8% | -49.0% |
Vanda Pharmaceuticals Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.94 M(-5.8%) |
| June 2024 | - | $8.43 M(-5.5%) |
| Mar 2024 | - | $8.92 M(-5.1%) |
| Dec 2023 | $9.40 M(-15.6%) | $9.40 M(-4.5%) |
| Sept 2023 | - | $9.85 M(-4.5%) |
| June 2023 | - | $10.31 M(-4.0%) |
| Mar 2023 | - | $10.73 M(-3.7%) |
| Dec 2022 | $11.14 M(-9.9%) | $11.14 M(+0.4%) |
| Sept 2022 | - | $11.10 M(-3.7%) |
| June 2022 | - | $11.53 M(-3.6%) |
| Mar 2022 | - | $11.96 M(-3.3%) |
| Dec 2021 | $12.37 M(-9.2%) | $12.37 M(-3.0%) |
| Sept 2021 | - | $12.75 M(-1.0%) |
| June 2021 | - | $12.88 M(-2.8%) |
| Mar 2021 | - | $13.25 M(-2.7%) |
| Dec 2020 | $13.61 M(-6.8%) | $13.61 M(+0.6%) |
| Sept 2020 | - | $13.54 M(-2.6%) |
| June 2020 | - | $13.90 M(-2.4%) |
| Mar 2020 | - | $14.24 M(-2.5%) |
| Dec 2019 | $14.60 M(>+9900.0%) | $14.60 M(-2.1%) |
| Sept 2019 | - | $14.92 M(-2.2%) |
| June 2019 | - | $15.25 M(-2.1%) |
| Mar 2019 | - | $15.57 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2018 | - | $0.00(0.0%) |
| June 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2016 | - | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2015 | - | $0.00(0.0%) |
| June 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2014 | - | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00 | $0.00(0.0%) |
| Sept 2013 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2012 | - | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2011 | - | $0.00(0.0%) |
| June 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2010 | - | $0.00(0.0%) |
| June 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00(0.0%) |
| June 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2008 | - | $0.00(0.0%) |
| June 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2007 | - | $0.00(0.0%) |
| June 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2006 | - | $400.00(-99.2%) |
| June 2006 | - | $48.90 K(-49.2%) |
| Mar 2006 | - | $96.30 K(-32.4%) |
| Dec 2005 | $142.50 K(-61.1%) | $142.50 K(>+9900.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00 |
| Dec 2004 | $366.70 K(-100.0%) | - |
| Dec 2003 | $4.06 B(-0.2%) | - |
| Dec 2002 | $4.07 B(+64.4%) | - |
| Dec 2001 | $2.48 B(-6.8%) | - |
| Dec 2000 | $2.66 B(+29.7%) | - |
| Dec 1999 | $2.05 B(-0.1%) | - |
| Dec 1998 | $2.05 B(+114.4%) | - |
| Dec 1997 | $956.70 M(+295.3%) | - |
| Dec 1996 | $242.00 M(-12.7%) | - |
| Dec 1995 | $277.20 M(+3.3%) | - |
| Dec 1994 | $268.40 M | - |
FAQ
- What is Vanda Pharmaceuticals annual total debt?
- What is the all time high annual total debt for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual total debt year-on-year change?
- What is Vanda Pharmaceuticals quarterly total debt?
- What is the all time high quarterly total debt for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals quarterly total debt year-on-year change?
What is Vanda Pharmaceuticals annual total debt?
The current annual total debt of VNDA is $9.40 M
What is the all time high annual total debt for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual total debt is $4.07 B
What is Vanda Pharmaceuticals annual total debt year-on-year change?
Over the past year, VNDA annual total debt has changed by -$1.74 M (-15.59%)
What is Vanda Pharmaceuticals quarterly total debt?
The current quarterly total debt of VNDA is $7.94 M
What is the all time high quarterly total debt for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly total debt is $15.57 M
What is Vanda Pharmaceuticals quarterly total debt year-on-year change?
Over the past year, VNDA quarterly total debt has changed by -$1.91 M (-19.36%)